NEWS
(Summary description)Biosimilars have made significant progress in recent times. Among them, China has released a draft guideline for biosimilars, outlining the direction for the supervision of such products this year, while the US FDA has accepted the first application for approval of biosimilars.
(Summary description)Biosimilars have made significant progress in recent times. Among them, China has released a draft guideline for biosimilars, outlining the direction for the supervision of such products this year, while the US FDA has accepted the first application for approval of biosimilars.
Biosimilars have made significant progress in recent times. Among them, China has released a draft guideline for biosimilars, outlining the direction for the supervision of such products this year, while the US FDA has accepted the first application for approval of biosimilars. China has become the 21st country to plan a clear development path for biosimilars, and its draft guidelines for biosimilars are so large that they follow the EU's management ideas.
Scan the QR code to read on your phone
丨News
Address: 6th Floor, Jiaba Business Building, Section 78, Qingnian Middle Road, Chongchuan District, Nantong City, Jiangsu Province
w e b：en.ntmeheco.com
Fax：+86-513-85513976
Email：admin@ntmeheco.com
Nantong foreign trade medicine and health products co. LTD. 苏ICP备2021047918号
Powered by www.300.cn
拨打电话 
客户留言